156 related articles for article (PubMed ID: 9328133)
21. Serum eosinophil cationic protein (ECP) is a sensitive measure for disease activity in atopic dermatitis.
Czech W; Krutmann J; Schöpf E; Kapp A
Br J Dermatol; 1992 Apr; 126(4):351-5. PubMed ID: 1571256
[TBL] [Abstract][Full Text] [Related]
22. Effect and correlation of serum total IgE, eosinophil granule cationic proteins and sensitized allergens in atopic dermatitis patients with or without rhinitis.
Wu CS; Yu CL; Chang CH; Kuo WR; Lin HJ; Yu HS
Kaohsiung J Med Sci; 2002 May; 18(5):229-35. PubMed ID: 12197429
[TBL] [Abstract][Full Text] [Related]
23. Monitoring of serologic immune parameters in inflammatory skin diseases.
Gebhardt M; Wenzel HC; Hipler UC; Herrmann D; Wollina U
Allergy; 1997 Nov; 52(11):1087-94. PubMed ID: 9404560
[TBL] [Abstract][Full Text] [Related]
24. Maternal serum soluble CD30 is increased in normal pregnancy, but decreased in preeclampsia and small for gestational age pregnancies.
Kusanovic JP; Romero R; Hassan SS; Gotsch F; Edwin S; Chaiworapongsa T; Erez O; Mittal P; Mazaki-Tovi S; Soto E; Than NG; Friel LA; Yoon BH; Espinoza J
J Matern Fetal Neonatal Med; 2007 Dec; 20(12):867-78. PubMed ID: 17853188
[TBL] [Abstract][Full Text] [Related]
25. Systemic ketoconazole is an effective treatment of atopic dermatitis with IgE-mediated hypersensitivity to yeasts.
Lintu P; Savolainen J; Kortekangas-Savolainen O; Kalimo K
Allergy; 2001 Jun; 56(6):512-7. PubMed ID: 11421895
[TBL] [Abstract][Full Text] [Related]
26. Maternal serum soluble CD30 is increased in pregnancies complicated with acute pyelonephritis.
Kusanovic JP; Romero R; Esoinoza J; Gotsch F; Edwin S; Chaiworapongsa T; Mittal P; Soto E; Erez O; Mazaki-Tovi S; Than NG; Friel LA; Yoon BH; Mazor M; Hassan SS
J Matern Fetal Neonatal Med; 2007 Nov; 20(11):803-11. PubMed ID: 17853184
[TBL] [Abstract][Full Text] [Related]
27. T-helper 2 involvement in the pathogenesis of bullous pemphigoid: role of soluble CD30 (sCD30).
De Pitá O; Frezzolini A; Cianchini G; Ruffelli M; Teofoli P; Puddu P
Arch Dermatol Res; 1997 Nov; 289(12):667-70. PubMed ID: 9452886
[TBL] [Abstract][Full Text] [Related]
28. Circulating soluble-CD30 (sCD30) in patients with HCV-related chronic hepatitis and in patients with alcoholic liver disease.
De Lazzari F; Ravagnan P; Tenderini M; Vicarioto MA; Galliani EA; Lorenzoni U; Popovic A; Floreani A
Hepatogastroenterology; 2002; 49(43):231-4. PubMed ID: 11941962
[TBL] [Abstract][Full Text] [Related]
29. Correlations of serum Interleukin-16, total IgE, eosinophil cationic protein and total eosinophil counts with disease activity in children with atopic dermatitis.
Wu KG; Li TH; Chen CJ; Cheng HI; Wang TY
Int J Immunopathol Pharmacol; 2011; 24(1):15-23. PubMed ID: 21496383
[TBL] [Abstract][Full Text] [Related]
30. Selected eosinophil proteins as markers of inflammation in atopic dermatitis patients.
Jenerowicz D; Czarnecka-Operacz M; Silny W
Acta Dermatovenerol Croat; 2006; 14(2):73-80. PubMed ID: 16859611
[TBL] [Abstract][Full Text] [Related]
31. Serum eosinophil cationic protein in patients with atopic dermatitis.
Paganelli R; Fanales-Belasio E; Carmini D; Scala E; Meglio P; Businco L; Aiuti F
Int Arch Allergy Appl Immunol; 1991; 96(2):175-8. PubMed ID: 1769747
[TBL] [Abstract][Full Text] [Related]
32. Circulating interleukin 16 (IL-16) in children with atopic/eczema dermatitis syndrome (AEDS): a novel serological marker of disease activity.
Frezzolini A; Paradisi M; Zaffiro A; Provini A; Cadoni S; Ruffelli M; De Pità O
Allergy; 2002 Sep; 57(9):815-20. PubMed ID: 12169178
[TBL] [Abstract][Full Text] [Related]
33. CD30 expression on CD1a+ and CD8+ cells in atopic dermatitis and correlation with disease severity.
Oflazoglu E; Simpson EL; Takiguchi R; Grewal IS; Hanifin JM; Gerber HP
Eur J Dermatol; 2008; 18(1):41-9. PubMed ID: 18086588
[TBL] [Abstract][Full Text] [Related]
34. CD30 expression on circulating memory CD4+ T cells as a Th2-dominated situation in patients with atopic dermatitis.
Yamamoto J; Adachi Y; Onoue Y; Kanegane H; Miyawaki T; Toyoda M; Seki T; Morohashi M
Allergy; 2000 Nov; 55(11):1011-8. PubMed ID: 11097309
[TBL] [Abstract][Full Text] [Related]
35. Elevation of serum-soluble E-selectin in atopic dermatitis.
Morita H; Kitano Y; Kawasaki N
J Dermatol Sci; 1995 Sep; 10(2):145-50. PubMed ID: 8534613
[TBL] [Abstract][Full Text] [Related]
36. [The effect of suplatast tosilate on immunological parameters for the patients with atopic dermatitis].
Suto H; Mitsuishi K; Hira K; Uchida T; Unno T; Ogawa H; Yoshiike T; Takamori K
Arerugi; 2000 Dec; 49(12):1163-72. PubMed ID: 11197882
[TBL] [Abstract][Full Text] [Related]
37. Elevated platelet activation in patients with atopic dermatitis and psoriasis: increased plasma levels of beta-thromboglobulin and platelet factor 4.
Tamagawa-Mineoka R; Katoh N; Ueda E; Masuda K; Kishimoto S
Allergol Int; 2008 Dec; 57(4):391-6. PubMed ID: 18797178
[TBL] [Abstract][Full Text] [Related]
38. Total IL-12 levels are increased in paediatric atopic dermatitis: correlations with age and disease severity.
Piancatelli D; Bellotta L; Del Beato T; Duse M; Della Penna MR
Int J Immunopathol Pharmacol; 2008; 21(2):359-65. PubMed ID: 18547480
[TBL] [Abstract][Full Text] [Related]
39. Serum mast cell tryptase is not a useful marker for disease severity in psoriasis or atopic dermatitis.
Gerdes S; Kurrat W; Mrowietz U
Br J Dermatol; 2009 Apr; 160(4):736-40. PubMed ID: 19076976
[TBL] [Abstract][Full Text] [Related]
40. Correlation of eosinophils, eosinophil cationic protein and soluble interleukin-2 receptor with the clinical activity of atopic dermatitis.
Kägi MK; Joller-Jemelka H; Wüthrich B
Dermatology; 1992; 185(2):88-92. PubMed ID: 1421636
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
